Long-term Outcomes of Cervical Adenocarcinoma Treated With Concurrent Chemoradiotherapy Using Paclitaxel and Cisplatin

Conclusion: TP-CCRT achieves a considerably better disease control for AC of the cervix, leading to a better OS.

Source: In Vivo - August 30, 2020 Category: Research Authors: ARAKAKI, Y., ARIGA, T., HEIANNA, J., SHIMOJI, Y., NAKASONE, T., TAIRA, Y., NAKAMOTO, T., OOYAMA, T., KUDAKA, W., KANESHIMA, I., NISHIHIRA, K., MEKARU, K., AOKI, Y. Tags: Clinical Studies Source Type: research